Sabra Health Care REIT, Inc. (SBRA)
- Previous Close
18.37 - Open
18.52 - Bid 18.37 x 500
- Ask 18.47 x 400
- Day's Range
18.37 - 18.67 - 52 Week Range
12.83 - 19.32 - Volume
1,403,815 - Avg. Volume
2,344,293 - Market Cap (intraday)
4.32B - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
80.17 - EPS (TTM)
0.23 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield 1.20 (6.51%)
- Ex-Dividend Date Aug 19, 2024
- 1y Target Est
18.59
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (?Senior Housing - Leased?), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing - Managed?), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
www.sabrahealth.com48
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA
View MorePerformance Overview: SBRA
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA
View MoreValuation Measures
Market Cap
4.32B
Enterprise Value
6.76B
Trailing P/E
80.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.45
Price/Book (mrq)
1.56
Enterprise Value/Revenue
10.12
Enterprise Value/EBITDA
19.96
Financial Highlights
Profitability and Income Statement
Profit Margin
7.85%
Return on Assets (ttm)
2.71%
Return on Equity (ttm)
1.83%
Revenue (ttm)
665.99M
Net Income Avi to Common (ttm)
52.28M
Diluted EPS (ttm)
0.23
Balance Sheet and Cash Flow
Total Cash (mrq)
63.38M
Total Debt/Equity (mrq)
89.03%
Levered Free Cash Flow (ttm)
224.2M